THE OUTLOOK FOR HEALTH CARE IN 2023:

What you need to know about the forces reshaping our industry.

X

Sponsored Content

Lung cancer screening guidelines summary

    Overview

    This table compares the United States Preventive Services Task Force (USPSTF) low-dose computed tomography (LDCT) lung cancer screening criteria to those established by the Centers for Medicare and Medicaid Services (CMS).

    Sponsored by
    The Lung Ambition Alliance logo

    This report is sponsored by AstraZeneca, in partnership with The Lung Ambition Alliance. Advisory Board experts wrote the report, conducting the underlying research independently and objectively. AstraZeneca had the opportunity to review the report.

     

    About the sponsor

    The Lung Ambition Alliance, a global coalition with partners across disciplines in over 50 countries, was formed to combat lung cancer through accelerating innovation and driving forward meaningful improvements for people with lung cancer. We do this by advocating for improved approaches in three areas: screening and early diagnosis, accelerated delivery of innovative medicine, and improved quality care.

    Learn more about The Lung Ambition Alliance

    This report is sponsored by AstraZeneca, an Advisory Board member organization. Representatives of AstraZeneca helped select the topics and issues addressed. Advisory Board experts wrote the report, maintained final editorial approval, and conducted the underlying research independently and objectively. Advisory Board does not endorse any company, organization, product or brand mentioned herein.

    To learn more, view our editorial guidelines.

    Have a Question?

    x

    Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.